Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Annals of Surgical Oncology|January 19, 2013
Locoregional lymphadenectomy in the surgical management of anorectal melanomaDaniel R Perez, Atthaphorn Trakarnsanga, Jinru Shia, et al.Frontiers in Oncology|November 10, 2022
Quality of life and function after rectal cancer surgery with and without sphincter preservationEmmanouil P Pappou, Larissa K Temple, Sujata Patil, et al.Annals of Surgery|June 6, 2012
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective studyPeirong Ding, David Liska, Peter Tang, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2013
Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysisTina Dasgupta, Diana Rothenstein, Joanne F Chou, et al.Diseases of the Colon and Rectum|July 31, 2007
Squamous-cell carcinoma of the rectum: a rare but curable tumorCaio S R Nahas, Jinru Shia, Romane Joseph, et al.The American Journal of Surgical Pathology|March 27, 2004
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcomeJinru Shia, Jose G Guillem, Harvey G Moore, et al.Journal of the National Cancer Institute|September 25, 2014
Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatmentAtthaphorn Trakarnsanga, Mithat Gönen, Jinru Shia, et al.Annals of Surgical Oncology|September 21, 2007
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiationCaio S R Nahas, Timothy Akhurst, Henry Yeung, et al.Diseases of the Colon and Rectum|June 17, 2006
Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment resultsGenevieve B Melton, Philip B Paty, Patrick J Boland, et al.The American Journal of Surgical Pathology|August 25, 2009
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panelJinru Shia, Laura H Tang, Efsevia Vakiani, et al.Pageof 11